Pharmacological IRS1/2 inhibition induces apoptosis in BCR-ABL1T315I mutant cells (2016)
Source: Abstracts. Conference titles: Annual Meeting and Exposition of the American Society of Hematology. Unidade: FMRP
Subjects: LEUCEMIA MIELOIDE, APOPTOSE
ABNT
SCOPIM-RIBEIRO, Renata et al. Pharmacological IRS1/2 inhibition induces apoptosis in BCR-ABL1T315I mutant cells. 2016, Anais.. San Diego: ASH, 2016. Disponível em: http://www.bloodjournal.org/content/128/22/1886. Acesso em: 29 jan. 2026.APA
Scopim-Ribeiro, R., Machado Neto, J. A., Eide, C. A., Campos, P. de M., Scheucher, P. S., Saad, S. T. O., et al. (2016). Pharmacological IRS1/2 inhibition induces apoptosis in BCR-ABL1T315I mutant cells. In Abstracts. San Diego: ASH. Recuperado de http://www.bloodjournal.org/content/128/22/1886NLM
Scopim-Ribeiro R, Machado Neto JA, Eide CA, Campos P de M, Scheucher PS, Saad STO, Rego EM, Tognon CE, Druker BJ, Traina F. Pharmacological IRS1/2 inhibition induces apoptosis in BCR-ABL1T315I mutant cells [Internet]. Abstracts. 2016 ;[citado 2026 jan. 29 ] Available from: http://www.bloodjournal.org/content/128/22/1886Vancouver
Scopim-Ribeiro R, Machado Neto JA, Eide CA, Campos P de M, Scheucher PS, Saad STO, Rego EM, Tognon CE, Druker BJ, Traina F. Pharmacological IRS1/2 inhibition induces apoptosis in BCR-ABL1T315I mutant cells [Internet]. Abstracts. 2016 ;[citado 2026 jan. 29 ] Available from: http://www.bloodjournal.org/content/128/22/1886
